Related Experiment Video
Updated: Oct 17, 2026

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
Relationship of cardiac troponin T and procoagulant activity in unstable angina
E Giannitsis1, M M Bardorff, S Schweikart
1Medizinische Klinik II der Medizinischen Universität zu Lübeck, Germany.
Insights
Cardiac troponin T (cTnT) levels in unstable angina patients indicate increased procoagulant activity. Elevated cTnT is closely linked to molecular markers of hemostatic activation, aiding in identifying patients needing intensified antithrombotic therapy.
Area of Science:
- Cardiology
- Hematology
- Biochemistry
Background:
- Unstable angina (UAP) is associated with increased thrombotic risk.
- Hemostatic activation plays a crucial role in the pathophysiology of UAP.
- Identifying patients with heightened procoagulant activity is essential for optimizing treatment.
Purpose of the Study:
- To determine the incidence of increased procoagulant activity in UAP patients.
- To evaluate the relationship between cardiac troponin T (cTnT) and molecular markers of hemostatic activation.
Main Methods:
- Studied 44 patients with UAP, stratified by plasma cTnT levels.
- Administered unfractionated heparin and acetylsalicylic acid to all patients.
- Serially measured cTnT, fibrin monomers (FM), prothrombin fragments F1+2, thrombin-antithrombin III complexes (TAT), plasminogen, and alpha2-antiplasmin within 48 hours.
Main Results:
- Increased FM detected in 45.5% of patients, more common with cTnT ≥ 0.1 ng/ml (p=0.003).
- Significant correlations found between cTnT and FM (r=0.74), and prothrombin fragments F1+2 (r=0.71).
- cTnT ≥ 0.1 ng/ml showed good sensitivity and specificity for identifying elevated hemostatic markers.
Conclusions:
- cTnT effectively identifies UAP patients with increased procoagulant activity.
- cTnT levels correlate closely with molecular markers of hemostatic activation.
- cTnT alone or combined with other markers can guide more potent antithrombotic therapy decisions.
Objective:
The present study sought to determine the incidence of increased procoagulant activity in patients with unstable angina (UAP), and to evaluate the relationship between cardiac troponin T (cTnT) and molecular markers of hemostatic activation. Method. We studied 44 patients with UAP further classified by plasma cTnT levels. All patients received an antithrombotic therapy consisting of therapeutic doses of unfractionated heparin and acetylsalicylic acid. Quantitative levels of cTnT and plasma concentrations of fibrin monomers (FM), prothrombin fragments F1+2, thrombin antithrombin III complexes (TAT), plasminogen and alpha2-antiplasmin were sampled serially within the first 48 h.
Results:
Increased plasma concentrations of FM were detected in 45.5% of patients and were more frequently present among those with cTnT concentrations > or =0.1 ng/ml (13 of 18 vs 7 of 26 patients, p = 0.003). In these patients, mean plasma concentrations of FM were significantly higher than in patients with cTnT <0.1 ng/ml (7.93 +/- 2.3 vs 3.12 +/- 0.6 microg/ml, p = 0.02). There was a close relationship between plasma levels of cTnT and FM (r = 0.74, p <0.004), prothrombin fragments F1+2 (r = 0.71, p = 0.046) and a trend to significance was noted for TAT (r = 0.42, p = 0.055). No significant correlation was observed with markers of the fibrinolytic system (plasminogen and alpha2-anti-plasmin). Plasma levels of cTnT > or =0.1 ng/ml identified a concomitant increase of hemostatic markers with a sensitivity, specificity and positive predictive value of 65, 79, and 72% for FM, 63, 76, and 67% for prothrombin fragments F1+2, and 58, 66, and 39% for TAT, respectively.
Conclusions:
In patients with UAP, cTnT identifies patients with increased procoagulant activity and is closely related to plasma levels of molecular markers of hemostatic activation. Therefore, cTnT alone or in combination with one of these markers may be helpful to identify patients requiring more potent antithrombin or antiplatelet therapy.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Angina II: Classification